Avid Radiopharmaceuticals

Acquired

Philadelphia, United States · Founded 2005 · $69.9M raised

Employees
51–200
Founded
2005
Business Model
B2B
Website
avidrp.com
Total Funding
$69.9M
Last Round
$34.5M Series DMay 2009
Rounds
4

About

Avid Radiopharmaceuticals is a Philadelphia-based molecular imaging company founded in 2005 and acquired by Eli Lilly in 2010, operating as a wholly-owned subsidiary. The company's mission is to discover, develop, and deliver diagnostic solutions that improve global health by accelerating the development of new medicines. Avid is best known for developing Amyvid (florbetapir F 18 injection), the first FDA-approved PET imaging agent for detecting amyloid plaques associated with Alzheimer's disease. Based at the University City Science Center research campus in Philadelphia, the company focuses on radiopharmaceutical diagnostics to advance neuroscience and other disease areas.

Summary

Avid Radiopharmaceuticals is a Biotech company based in Philadelphia, United States, founded in 2005. It has raised $69.9M in total across 4 rounds, most recently a $34.5M Series D round in May 2009. Investors include Eli Lilly, Alta Partners and Pfizer Ventures.

Funding History

Series DSeries DMay 2009
$34.5M

Sign up to see all 5 rounds

Acquisition through Series D — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Avid Radiopharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/avid-radiopharmaceuticals"><img src="https://indexed.vc/api/badge/company/avid-radiopharmaceuticals" alt="Avid Radiopharmaceuticals on Indexed.vc" width="260" height="76" /></a>